| Literature DB >> 29664388 |
Jaime Martinez-Urtaza, Joaquin Trinanes, Michel Abanto, Antonio Lozano-Leon, Jose Llovo-Taboada, Marta Garcia-Campello, Anxela Pousa, Andy Powell, Craig Baker-Austin, Narjol Gonzalez-Escalona.
Abstract
Galicia in northwestern Spain has been considered a hotspot for Vibrio parahaemolyticus infections. Infections abruptly emerged in 1998 and, over the next 15 years, were associated with large outbreaks caused by strains belonging to a single clone. We report a recent transition in the epidemiologic pattern in which cases throughout the region have been linked to different and unrelated strains. Global genome-wide phylogenetic analysis revealed that most of the pathogenic strains isolated from infections were associated with globally diverse isolates, indicating frequent episodic introductions from disparate and remote sources. Moreover, we identified that the 2 major switches in the epidemic dynamics of V. parahaemolyticus in the regions, the emergence of cases and an epidemiologic shift in 2015-2016, were associated with the rise of sea surface temperature in coastal areas of Galicia. This association may represent a fundamental contributing factor in the emergence of illness linked to these introduced pathogenic strains.Entities:
Keywords: Galicia; Spain; Vibrio parahaemolyticus; bacteria; climate change; enteric infections; epidemiology; food safety; gastroenteritis; global phylogeny; seafood safety; warming; whole-genome sequencing
Mesh:
Substances:
Year: 2018 PMID: 29664388 PMCID: PMC5938774 DOI: 10.3201/eid2405.171700
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
Characteristics of Vibrio parahaemolyticus strains sequenced and analyzed for study of epidemic dynamics, 1998–2016*
| Strain | CFSAN no. | Year | Source | ST |
|
| Accession no.† | Reference |
|---|---|---|---|---|---|---|---|---|
| Strains identified in Spain | ||||||||
| 30824 | CFSAN018753 | 1999 | Clinical | ST17 | + | – | LHAV00000000 | ( |
| 428–00 | CFSAN018752 | 1998 | Clinical | ST17 | + | – | LHAU00000000 | ( |
| 9808–1 | CFSAN018754 | 2004 | Clinical | ST3 | + | – | LHAW00000000 | ( |
| 118 | CFSAN045068 | 2015 | Clinical | ST1031 | + | – | SRR5163839 | This study |
| 119 | CFSAN045069 | 2015 | Clinical | ST1031 | + | – | SRR5163836 | This study |
| 113477 | CFSAN045070 | 2015 | Clinical | ST327 | + | – | SRR5163834 | This study |
| AMC 317 | CFSAN056086 | 2016 | Clinical | ST3 | + | – | SRR5163849 | This study |
| AMC 325 | CFSAN056088 | 2016 | Clinical | ST1031 | + | – | SRR5163835 | This study |
| G25 | CFSAN022330 | 2012 | Clinical | ST36 | + | + | LHRR00000000 | This study |
| G30 | CFSAN022331 | 2012 | Clinical | ST36 | + | + | LHRS00000000 | This study |
| G31 | CFSAN022332 | 2012 | Clinical | ST36 | + | + | LHRT00000000 | This study |
| G32 | CFSAN022337 | 2012 | Clinical | ST1032 | – | + | SRR5163840 | This study |
| G33 | CFSAN022333 | 2012 | Clinical | ST1031 | – | + | SRR5163848 | This study |
| G35 | CFSAN022336 | 2012 | Clinical | ST36 | + | + | LHRW00000000 | This study |
| G36 | CFSAN022335 | 2012 | Clinical | ST36 | + | + | LHRV00000000 | This study |
| G37 | CFSAN022334 | 2012 | Clinical | ST36 | + | + | LHRU00000000 | This study |
| N310 | CFSAN053627 | 2016 | Clinical | ST327 | + | – | SRR5163837 | This study |
| N314 | CFSAN053626 | 2016 | Clinical | ST3 | + | – | SRR5163842 | This study |
| OAG100 | CFSAN025076 | 2007 | Shellfish | ST1121 | + | + | SRR5163838 | This study |
| OAG95 | CFSAN025079 | 2007 | Shellfish | NA | – | + | SRS1912582 | This study |
| OAG99 | CFSAN025078 | 2007 | Shellfish | ST1121 | + | + | SRS1912583 | This study |
| OJL90 | CFSAN029659 | 2007 | Shellfish | ST331 | + | – | SRR5163850 | This study |
| PH157 | CFSAN025074 | 2006 | Zooplankton | ST331 | NA | NA | SRR5163833 | This study |
| PQ110 | CFSAN029660 | 2006 | Zooplankton | ST79 | – | + | SRR5163846 | This study |
| PY194 | CFSAN025072 | 2007 | Zooplankton | ST199 | + | + | SRR5163847 | This study |
| PY233 | CFSAN025077 | 2006 | Zooplankton | ST169 | – | – | SRS1912575 | This study |
| PY350 | CFSAN025073 | 2006 | Zooplankton | ST1032 | – | + | SRR5163841 | This study |
| PY452 | CFSAN025075 | 2007 | Zooplankton | ST1032 | + | – | SRS1912576 | This study |
| PY456 | CFSAN025071 | 2006 | Zooplankton | ST1032 | – | + | SRR5163847 | This study |
| UCM-V441 | CFSAN018755 | 2002 | Shellfish | ST52 | – | – | LHAX00000000 | This study |
| UCM-V493 | NA | 2002 | Sediment | ST471 | – | – | CP007005, CP007004 | This study |
| UCM-V586 | CFSAN018756 | 2003 | Shellfish | NA | – | – | LHAY00000000 | This study |
| Strains identified in the United Kingdom | ||||||||
| 14-1072-D-VP | CFSAN029647 | 2014 | Shellfish | ST1159 | – | + | SRR5639920 | This study |
| 14-1073-H-VP | CFSAN029643 | 2014 | Shellfish | ST1159 | – | + | SRR5639916 | This study |
| 14-1498-F-VP | CFSAN029646 | 2014 | Shellfish | ST1158 | – | + | SRR5639919 | This study |
| 14-1499-VP | CFSAN029645 | 2014 | Shellfish | ST1157 | + | + | SRR5639914 | This study |
| 14-559-B-VP | CFSAN029644 | 2014 | Shellfish | ST1159 | – | + | SRR5639913 | This study |
| 14-692-A-1-VP | CFSAN029642 | 2014 | Shellfish | ST1159 | – | + | SRR5639915 | This study |
| V12-024 | CFSAN029651 | 2014 | Clinical | ST3 | + | – | SRR5639912 | This study |
| V05-002 | CFSAN029650 | 1972 | Clinical | ST331 | + | – | SRR5639911 | This study |
| V06-002 | CFSAN029649 | 1980 | Clinical | ST17 | + | – | SRR5639918 | This study |
| F3305-VP | CFSAN029648 | 2005 | Clinical | ST262 | + | – | SRR5639917 | This study |
*CFSAN, Center for Food Safety and Applied Nutrition; NA, not applicable; SRA, Sequence Read Archive; ST, sequence type; +, positive; –, negative. †National Center for Biotechnology Information Assembly or Sequence Read Archive database.
Figure 1Phylogenetic reconstruction of Vibrio parahaemolyticus based on 738 available genomes. Red dots indicate isolates from Spain collected over the past 20 years from clinical settings and environmental sources. Colors represent sequence types, and areas without color correspond to undetermined sequence types. Scale bars represent nucleotide substitutions per site.
Figure 2Phylogeny of Vibrio parahaemolyticus isolates from Galicia, Spain. A) Phylogenetic inference of the 42 genomes from Spain identified in this study (red text) along with all other genomes identified in the same clusters by the global phylogeny with their corresponding sequence types (STs). B) Phylogenetic tree of genomes belonging to ST3 (pandemic clone). C) Phylogenetic tree of genomes included in ST36 in the global phylogeny. Gray dots indicate bootstrap values supporting the nodes; dot sizes indicate 80% (smallest) to 100% (largest). Values <80% are not shown. Scale bars represent nucleotide substitutions per site. ND, not determined.
Figure 3Recent environmental warming trends in Galicia, Spain, 1982–2016. Trends in the mean values of SST were estimated using daily SST data from a coastal area defined by the coordinates 42°–43°N and 8.5°–9.5°W. A) Mean SST records show stepwise changes rather than a linear pattern. Two regime shifts occurred in June 1994 (0.4°C warming) and June 2014 (0.7°C), which correspond with the first emergence of Vibrio parahaemolyticus cases and the epidemiologic shifts observed for 2015 and 2016. B) Number of days with SST >18°C (blue dot), 5-year moving average (blue line), and regression line (yellow line); slope is of ≈1 d/y (e.g., gaining 1 d/y). C) Mean SST data for Galicia for 2 periods, demonstrating the generalized warming and expansion of season with favorable conditions for sustaining Vibrio organisms in the environment and hence increasing risk of infection. SST, sea surface temperature.